Methods of Treating Hair Related Conditions
US-2016338927-A1 · Nov 24, 2016 · US
Alkylamido compounds and uses thereof
US10137101B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10137101-B2 |
| Application number | US-201615337707-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 28, 2016 |
| Priority date | Feb 16, 2009 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating acne in a subject in need thereof, the method comprising administering a therapeutically effective amount of N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid, or a pharmaceutically acceptable salt or a pharmaceutically acceptable N-oxide thereof. 2. The method of claim 1 , wherein the acne is at least one of: acne vulgaris, comedo-type acne, polymorphic acne, acne rosacea, nodulocystic acne, acne conglobata, senile acne, secondary acne, solar acne, acne medicamentosa or occupational acne, or acne hyperseborrhoea. 3. The method of claim 1 , wherein N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid, or a pharmaceutically acceptable salt or a pharmaceutically acceptable N-oxide thereof, is administered orally or topically. 4. A method of treating acne in a subject in need thereof, the method comprising administering a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises: a therapeutically effective amount of N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid, or a pharmaceutically acceptable salt or a pharmaceutically acceptable N-oxide thereof; and a pharmaceutically acceptable carrier. 5. The method of claim 4 , wherein the acne is at least one of: acne vulgaris, comedo-type acne, polymorphic acne, acne rosacea, nodulocystic acne, acne conglobata, senile acne, secondary acne, solar acne, acne medicamentosa or occupational acne, and acne hyperseborrhoea. 6. The method of claim 4 , wherein the pharmaceutical composition is administered orally or topically.
Assignees
Inventors
Classifications
Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof · CPC title
Preparations for oily skin · CPC title
Preparations for affecting hair growth · CPC title
Anti-acne agents · CPC title
- A61K31/196Primary
the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10137101B2 cover?
- Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.
- Who is the assignee on this patent?
- Nogra Pharma Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K31/196. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).